Cancer Risk Assessment Calculator


Answer a short questionnaire about your health, habits and family. You get three things back: validated risk estimates for lung and breast cancer where you fit the published models, screening worth discussing with your doctor, and a summary of risk factors in your answers, with what you can do about them. It takes about 5 minutes. Your answers never leave your browser.

This is an information tool, not a diagnosis. If you have symptoms, see a doctor whatever the result says.

Loading...

How this calculator works

The tool follows a strict evidence rule: it only shows a percentage when a published, externally validated model exists and you fit that model's scope. It never builds a personal number by multiplying published relative risks together. Doing so ignores how risk factors overlap and interact, and gives misleading results.

Evidence levelWhat you see
Validated model (Tier A)A percentage with its time horizon, the model name, the population it was built in, and whether it applies to you.
Established risk factor (Tier C)A plain-language note on the factor and what helps, with no percentage.
SymptomsA separate message to see a doctor. Symptoms never change the risk numbers.

Lung cancer: PLCOm2012

For people who have smoked, the tool estimates the chance of a lung cancer diagnosis in the next 6 years. The model is logistic regression and was developed in about 80,000 people who had smoked, from the US Prostate, Lung, Colorectal and Ovarian (PLCO) trial. It has been validated in the US National Lung Screening Trial and in screening programmes in Canada, the UK, Europe and Australia.

Its inputs are:

  • age, education, BMI and ethnic background
  • COPD, previous cancer and family history of lung cancer
  • whether you smoke now, cigarettes per day, years smoked and years since quitting

Risk = 1 / (1 + e−x), where x = −4.532506 + 0.0778868×(age−62) − 0.0812744×(education−4) − 0.0274194×(BMI−27) + 0.3553063×COPD + 0.4589971×previous cancer + 0.587185×family history + 0.2597431×current smoker − 1.822606×(10/cigarettes per day − 0.4021541613) + 0.0317321×(years smoked−27) − 0.0308572×(years quit−10) + ethnicity term

Ethnicity terms: Black +0.3944778, Hispanic −0.7434744, Asian −0.466585, Native Hawaiian / Pacific Islander +1.027152; White and American Indian / Alaska Native 0.

If you answer “Don't know” for COPD, previous cancer, family history or education, the tool shows a range instead of guessing.

Several screening programmes offer low-dose CT when the 6-year risk is 1.51% or more.

Breast cancer: NCI Breast Cancer Risk Assessment Tool (Gail model)

For women aged 35 to 85, the tool estimates the risk of invasive breast cancer over the next 5 years and up to age 90. It also shows the risk for an average woman of the same age and ethnic group. The calculation is a direct port of the US National Cancer Institute's BCRA R package (version 2.1): the same relative-risk categories, the same race-specific incidence, mortality and attributable-risk tables, and the same handling of “unknown” answers.

The model is not used, and the tool says why, after:

  • breast cancer, DCIS or LCIS
  • chest radiation before age 30
  • a known high-risk gene change, in you or your family

In those cases, specialist assessment is needed.

Screening guidance

Screening suggestions follow these guidelines:

  • US Preventive Services Task Force: breast 2024, colorectal 2021, lung 2021, prostate 2018
  • World Health Organization: cervical screening, 2021

Screening eligibility and cancer risk are different questions. National programmes differ, so follow the programme where you live.

Derived values

  • BMI = weight (kg) ÷ height (m)²
  • Pack-years = cigarettes per day ÷ 20 × years smoked. This applies to cigarettes only, not to smokeless tobacco or vaping.
  • Alcohol: grams of pure alcohol per day = drink volume (ml) × % alcohol × 0.789 ÷ 7, using your own drink sizes, because a “standard drink” differs between countries.
  • Activity = moderate minutes + 2 × vigorous minutes per week, as in the WHO guidelines.

Accuracy check

Both models were tested against the reference code:

  • 200 random lung profiles against the PLCOm2012 R function
  • 1,600 breast calculations (5-year, lifetime and average-woman risks) against the NCI BCRA R package, plus the package's own example data, including the invalid inputs it rejects

All results agreed to better than 0.000000001 percentage points.

Limitations

  • Both models were developed with US data. The lung model has been validated in several other high-income countries; the breast model uses US cancer rates and is likely to overestimate risk in countries with lower breast cancer rates.
  • Most cancers have no validated personal risk calculator, so they appear only in the factor summary.
  • A low estimate does not mean zero risk and cannot rule out an existing cancer.
  • The models do not include genetics, breast density or detailed family history. If those apply to you, ask about specialist tools such as Tyrer-Cuzick (IBIS) or CanRisk (BOADICEA).

Privacy

The questionnaire runs entirely in your browser. Your answers are not sent to CalculatorEdge or anyone else, not stored, and not added to the page address. Use “Print or save as PDF” to keep a copy for your doctor.

Sources

  • Tammemägi MC et al. Selection criteria for lung-cancer screening. N Engl J Med 2013;368:728–736 (PLCOm2012).
  • Tammemägi MC et al. USPSTF2013 versus PLCOm2012 lung cancer screening eligibility criteria (International Lung Screening Trial). Lancet Oncol 2022.
  • Gail MH et al. J Natl Cancer Inst 1989;81:1879–1886, and later updates for African-American (CARE), Hispanic and Asian-American women; NCI BCRA R package 2.1 and the NCI Breast Cancer Risk Assessment Tool.
  • US Preventive Services Task Force recommendations on screening for lung, breast, colorectal and prostate cancer.
  • World Health Organization. Guideline for screening and treatment of cervical pre-cancer lesions, 2nd edition, 2021.
  • Lauby-Secretan B et al. Body fatness and cancer – viewpoint of the IARC Working Group. N Engl J Med 2016;375:794–798.
  • IARC Monographs: tobacco smoking, second-hand smoke and smokeless tobacco (vol. 100E); betel quid and areca nut (vol. 85); alcohol; red and processed meat (vol. 114).
  • WHO guidelines on physical activity and sedentary behaviour, 2020. WHO/Europe statement on alcohol, Lancet Public Health 2023.

Content reviewed November 2026. Guidelines change; check the date before relying on screening advice.